SEARCH

SEARCH BY CITATION

References

  • Dynek, J.N., Goncharov, T., Dueber, E.C., Fedorova, A.V., Izrael-Tomasevic, A., Phu, L., Helgason, E., Fairbrother, W.J., Deshayes, K., Kirkpatrick, D.S. & Vucic, D. (2010) c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29, 41984209.
  • Gyrd-Hansen, M. & Meier, P. (2010) IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer. Nat. Rev. Cancer 10, 561574.
  • Hinz, M., Stilmann, M., Arslan, S.C., Khanna, K.K., Dittmar, G. & Scheidereit, C. (2010) A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation. Mol. Cell 40, 6374.
  • Jabara, H., Laouini, D., Tsitsikov, E., Mizoguchi, E., Bhan, A., Castigli, E., Dedeoglu, F., Pivniouk, V., Brodeur, S. & Geha, R. (2002) The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 17, 265276.
  • Kanazawa, K. & Kudo, A. (2005) TRAF2 is essential for TNF-α-induced osteoclastogenesis. J. Bone Miner. Res. 20, 840847.
  • Karsenty, G. & Wagner, E.F. (2002) Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389406.
  • Kim, J.H., Kim, K., Jin, H.M., Song, I., Youn, B.U., Lee, S.H., Choi, Y. & Kim, N. (2010a) Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1. J. Biol. Chem. 285, 52245231.
  • Kim, S., Ohoka, N., Okuhira, K., Sai, K., Nishimaki-Mogami, T. & Naito, M. (2010b) Modulation of RIP1 ubiquitylation and distribution by MeBS to sensitize cancer cells to tumor necrosis factor alpha-induced apoptosis. Cancer Sci. 101, 24252429.
  • Kobayashi, N., Kadono, Y., Naito, A., Matsumoto, K., Yamamoto, T., Tanaka, S. & Inoue, J. (2001) Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 20, 12711280.
  • Lee, S.E., Woo, K.M., Kim, S.Y., Kim, H.M., Kwack, K., Lee, Z.H. & Kim, H.H. (2002) The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30, 7177.
  • Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., McLean, M., Ikeda, J.E., MacKenzie, A. & Korneluk, R.G. (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379, 349353.
  • Lopez, J., John, S.W., Tenev, T., Rautureau, G.J., Hinds, M.G., Francalanci, F., Wilson, R., Broemer, M., Santoro, M.M., Day, C.L. & Meier, P. (2011) CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol. Cell 42, 569583.
  • Mahoney, D.J., Cheung, H.H., Mrad, R.L., Plenchette, S., Simard, C., Enwere, E., Arora, V., Mak, T.W., Lacasse, E.C., Waring, J. & Korneluk, R.G. (2008) Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl Acad. Sci. USA 105, 1177811783.
  • Mao, A.P., Li, S., Zhong, B., Li, Y., Yan, J., Li, Q., Teng, C. & Shu, H.B. (2010) Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-β (IFN-β) and cellular antiviral response. J. Biol. Chem. 285, 94709476.
  • Matsuzawa, A., Tseng, P.H., Vallabhapurapu, S., Luo, J.L., Zhang, W., Wang, H., Vignali, D.A., Gallagher, E. & Karin, M. (2008) Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663668.
  • Nguyen, L.T., Duncan, G.S., Mirtsos, C., Ng, M., Speiser, D.E., Shahinian, A., Marino, M.W., Mak, T.W., Ohashi, P.S. & Yeh, W.C. (1999) TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity 11, 379389.
  • Novack, D.V., Yin, L., Hagen-Stapleton, A., Schreiber, R.D., Goeddel, D.V., Ross, F.P. & Teitelbaum, S.L. (2003) The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis. J. Exp. Med. 198, 771781.
  • Rodan, G.A. & Martin, T.J. (2000) Therapeutic approaches to bone diseases. Science 289, 15081514.
  • Sekine, K., Takubo, K., Kikuchi, R., Nishimoto, M., Kitagawa, M., Abe, F., Nishikawa, K., Tsuruo, T. & Naito, M. (2008) Small molecules destabilize cIAP1 by activating auto-ubiquitylation. J. Biol. Chem. 283, 89618968.
  • Taguchi, Y., Gohda, J., Koga, T., Takayanagi, H. & Inoue, J. (2009) A unique domain in RANK is required for Gab2 and PLCγ2 binding to establish osteoclastogenic signals. Genes Cells 14, 13311345.
  • Takayanagi, H. (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292304.
  • Vaira, S., Johnson, T., Hirbe, A.C., Alhawagri, M., Anwisye, I., Sammut, B., O'Neal, J., Zou, W., Weilbaecher, K.N., Faccio, R. & Novack, D.V. (2008) RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation. Proc. Natl Acad. Sci. USA 105, 38973902.
  • Varfolomeev, E., Blankenship, J.W., Wayson, S.M., Fedorova, A.V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J.N., Elliott, L.O., Wallweber, H.J., Flygare, J.A., Fairbrother, W.J., Deshayes, K., Dixit, V.M. & Vucic, D. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669681.
  • Varfolomeev, E., Goncharov, T., Maecker, H., Zobel, K., Komuves, L.G., Deshayes, K. & Vucic, D. (2012) Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors. Sci. Signal. 5, ra22.
  • Vischioni, B., Giaccone, G., Span, S.W., Kruyt, F.A. & Rodriguez, J.A. (2004) Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2. Exp. Cell Res. 298, 535548.
  • Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V. & Baldwin, A.S., Jr (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 16801683.
  • Wang, L., Du, F. & Wang, X. (2008) TNF-α induces two distinct Caspase-8 activation pathways. Cell 133, 693703.
  • Werneburg, B.G., Zoog, S.J., Dang, T.T., Kehry, M.R. & Crute, J.J. (2001) Molecular characterization of CD40 signaling intermediates. J. Biol. Chem. 276, 4333443342.
  • Yamaguchi, N., Ito, T., Azuma, S., Ito, E., Honma, R., Yanagisawa, Y., Nishikawa, A., Kawamura, M., Imai, J., Watanabe, S., Semba, K. & Inoue, J. (2009) Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines. Cancer Sci. 100, 16681674.
  • Yasuda, H., Shima, N., Nakagawa, N., et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl Acad. Sci. USA 95, 35973602.